Dr Robert Weinkove
The aim of this novel and ambitious project is to develop potent new vaccines with potential to prevent recurrence of HER2 positive breast cancer.
Targeting HIF-1 In Triple Negative Breast Cancer Using Glutaminase Inhibitors
Dr Dean Singleton
It is now understood that Triple Negative breast cancer has many biologic nuances and a heterogeneity not previously understood.
Targeting Breast Cancer Metastasis With Heparan Sulfate Mimetics
Professor John Miller
This research team combines leading expertise in synthetic and medicinal chemistry and cancer biology.
Investigating Fn14 As A Driver Of Breast Cancer Metastasis
Dr Heather Cunliffe
The presence of a protein called Fn14 on the surface of 75% of invasive breast cancers, has been shown to be strongly prognostic for distant metastasis, with the strongest association in HER2/neu positive and Triple Negative breast cancers.